Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools

Y Wang, JL Hou - Hepatology international, 2016 - Springer
Fibrosis, a common pathogenic pathway of chronic liver disease (CLD), has long been
indicated to be significantly and most importantly associated with severe prognosis …
被引用次数：20 相关文章

Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools

Y Wang, JL Hou - Hepatology International, 2016 - infona.pl
Fibrosis, a common pathogenic pathway of chronic liver disease (CLD), has long been
indicated to be significantly and most importantly associated with severe prognosis …

Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools

Y Wang, JL Hou - Hepatology international, 2016 - pubmed.ncbi.nlm.nih.gov
Fibrosis, a common pathogenic pathway of chronic liver disease (CLD), has long been
indicated to be significantly and most importantly associated with severe prognosis …

Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools.

Y Wang, JL Hou - Hepatology International, 2016 - europepmc.org
Fibrosis, a common pathogenic pathway of chronic liver disease (CLD), has long been
indicated to be significantly and most importantly associated with severe prognosis …

Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools

Y Wang, J Hou - Hepatology international., 2016 - search.proquest.com
Fibrosis, a common pathogenic pathway of chronic liver disease (CLD), has long been
indicated to be significantly and most importantly associated with severe prognosis …

[引用][C] Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools

Y Wang, JL Hou - Hepatology international, 2016 - Springer